PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

In this episode of the podcast, Joe interviews James Lanthier, the CEO of Mindset Pharma; a biotechnology company discovering and developing new (and hopefully safer, more predictable, and more palatable) psychedelic compounds. www.psychedelicstoday.com

Episode metadata supplied by the publisher feed · Published Jun 28, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

0:00 1:03:36

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Psychedelics Today?

This episode is 1 hour and 3 minutes long.

When was this Psychedelics Today episode published?

This episode was published on June 28, 2022.

Can I download this Psychedelics Today episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!